A mathematical model for the effects of HER2 overexpression on cell proliferation in breast cancer

被引:21
|
作者
Eladdadi, Amina [1 ]
Isaacson, David [1 ]
机构
[1] Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA
关键词
HER2; cell proliferation; receptor modeling; mathematical modeling;
D O I
10.1007/s11538-008-9315-4
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We present a mathematical model to study the effects of HER2 over-expression on cell proliferation in breast cancer. The model illustrates the proliferative behavior of cells as a function of HER2 and EGFR receptors numbers, and the growth factor EGF. This mathematical model comprises kinetic equations describing the cell surface binding of EGF growth factor to EGFR and HER2 receptors, coupled to a model for the dependence of cell proliferation rate on growth factor receptors binding. The simulation results from this model predict: (1) a growth advantage associated with excess HER2 receptors; (2) that HER2-over-expression is an insufficient parameter to predict the proliferation response of cancer cells to epidermal growth factors; and (3) the EGFR receptor expression level in HER2-over-expressing cells plays a key role in mediating the proliferation response to receptor-ligand signaling. This mathematical model also elucidates the interaction and roles of other model parameters in determining cell proliferation rate of HER2-over-expressing cells.
引用
收藏
页码:1707 / 1729
页数:23
相关论文
共 50 条
  • [21] Diagnosis of HER2 protein overexpression in patients with breast cancer in Brazil
    Muranaka, A. H.
    VALUE IN HEALTH, 2008, 11 (03) : A54 - A54
  • [22] Association between HER2/neu overexpression and calcifications in breast cancer
    Christy, C. J.
    Rishi, M.
    Schwartz, J.
    Grube, B. J.
    Bossuyt, V.
    Philpotts, L.
    DiGiovanna, M. P.
    Tavassoli, F.
    Lannin, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] The Cooperation between hMena Overexpression and HER2 Signalling in Breast Cancer
    Di Modugno, Francesca
    Mottolese, Marcella
    DeMonte, Lucia
    Trono, Paola
    Balsamo, Michele
    Conidi, Andrea
    Melucci, Elisa
    Terrenato, Irene
    Belleudi, Francesca
    Torrisi, Maria Rosaria
    Alessio, Massimo
    Santoni, Angela
    Nistico, Paola
    PLOS ONE, 2010, 5 (12):
  • [24] HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer
    Moliterni, A
    Ménard, S
    Valagussa, P
    Biganzoli, E
    Boracchi, P
    Balsari, A
    Casalini, P
    Tomasic, G
    Marubini, E
    Pilotti, S
    Bonadonna, G
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (03) : 458 - 462
  • [25] HER2 overexpression drives Warburg effect in breast cancer cells
    Ozer, U.
    FEBS JOURNAL, 2016, 283 : 250 - 251
  • [26] The predictive role of HER2 overexpression in early breast cancer - Reply
    Menard, S
    Biganzoli, E
    Valagussa, P
    Boracchi, P
    Moliterni, A
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3180 - 3180
  • [27] Effects of X-ray irradiation on the overexpression of HER2/Erb-B2 on breast cancer cell lines
    Juranic, ZD
    Borojevic, N
    Jovanovic, D
    Stanojevic-Bakic, N
    Zizak, Z
    Neskovic-Konstantinovic, Z
    Saric, N
    Stanojkovic, T
    Raonic, T
    Milosevic, D
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2004, 23 (04) : 675 - 680
  • [28] A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
    Reix, Nathalie
    Malina, Charlotte
    Chenard, Marie-Pierre
    Bellocq, Jean-Pierre
    Delpous, Stephanie
    Moliere, Sebastien
    Sevrin, Anthony
    Neuberger, Karl
    Tomasetto, Catherine
    Mathelin, Carole
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (02) : 249 - 259
  • [29] A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
    Nathalie Reix
    Charlotte Malina
    Marie-Pierre Chenard
    Jean-Pierre Bellocq
    Stéphanie Delpous
    Sébastien Molière
    Anthony Sevrin
    Karl Neuberger
    Catherine Tomasetto
    Carole Mathelin
    Breast Cancer Research and Treatment, 2016, 160 : 249 - 259
  • [30] Prostate cancer cell lines lack amplification:: Overexpression of HER2
    Ullén, A
    Lennartsson, L
    Harmenberg, U
    Lennernäs, B
    Majumder, K
    Holmberg, AR
    Nilsson, S
    Elmberger, PG
    ACTA ONCOLOGICA, 2005, 44 (05) : 490 - 495